Screener / SEC EDGAR /CIK 0001361113 /10-K filed Feb 4, 2026, compared with Feb 6, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Software

Varonis Systems Inc VRNS

Compare with peers Embed
Planned sales, announced before they happen

0 trading plans running

10-Q, 10-K and Form 144
Plans running now 0 none adopted and not yet ended or expired
Plans adopted 7 reported since May 2, 2023 Form 144 notices 0 none downloaded

What VRNS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Mar 14, 2024 to Nov 16, 2026. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.

InsiderWhatDateReported in
Guy Melamed
Chief Financial Officer and Chief Operating Officer
Ended 10b5-1 plan Feb 11, 2026 10-Q Apr 29, 2026
What the company wrote
On February 11, 2026, Guy Melamed, our Chief Financial Officer and Chief Operating Officer, terminated a Rule 10b5–1 trading arrangement that was previously adopted on September 15, 2025. Mr. Melamed’s terminated Rule 10b5–1 trading arrangement would have expired on September 10, 2026, if not earlier terminated, and included the potential sale of up to 94,502 vested shares of our common stock and up to 100% of restricted and performance stock units (net of stock units withheld for taxes) scheduled to vest in February 2026. As of the date of termination of the Rule 10b5–1 trading arrangement, no shares of our common stock had been sold under its terms.
Yakov Faitelson
Chief Executive Officer, President and Chairman of the Board
Ended 10b5-1 plan Oct 30, 2025 10-K Feb 4, 2026
Guy Melamed
Chief Financial Officer and Chief Operating Officer
Adopted 10b5-1 plan Sep 15, 2025 10-Q Oct 29, 2025
What the company wrote
On September 15, 2025, Guy Melamed, our Chief Financial Officer and Chief Operating Officer, entered into a Rule 10b5–1 trading arrangement. Mr. Melamed’s arrangement includes the potential sale of up to 94,502 vested shares of our common stock and up to 100% of restricted and performance stock units (net of stock units withheld for taxes) scheduled to vest in February 2026, and expires on September 10, 2026, unless earlier terminated in accordance with the provisions of the arrangement. Mr. Melamed’s arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Yakov Faitelson
Chief Executive Officer, President and Chairman of the Board
Adopted 10b5-1 plan Sep 15, 2025 10-Q Oct 29, 2025
What the company wrote
On September 15, 2025, Yakov Faitelson, our Chief Executive Officer, President and Chairman of the Board, entered into a Rule 10b5–1 trading arrangement. Mr. Faitelson’s arrangement includes the potential sale of up to 217,521 shares of our common stock, and expires on June 30, 2026, unless earlier terminated in accordance with the provisions of the arrangement. Mr. Faitelson’s arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Dov Gottlieb
Vice President, General Counsel and Corporate Secretary
Adopted 10b5-1 plan Sep 11, 2025 10-Q Oct 29, 2025
What the company wrote
On September 11, 2025, Dov Gottlieb, our Vice President, General Counsel and Corporate Secretary, entered into a Rule 10b5–1 trading arrangement. Mr. Gottlieb’s arrangement includes the potential sale of up to 78,838 vested shares of our common stock and up to 100% of restricted and performance stock units (net of stock units withheld for taxes) scheduled to vest in February and May 2026, and expires on August 31, 2026, unless earlier terminated in accordance with the provisions of the arrangement. Mr. Gottlieb’s arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Fred Van den Bosch
Director
Adopted 10b5-1 plan Dec 3, 2024 10-K Feb 6, 2025
What the company wrote
On December 3, 2024, Fred Van den Bosch, Director, entered into a Rule 10b5–1 trading arrangement. Mr. Van den Bosch’s arrangement includes the potential sale of up to 18,000 shares of our common stock, and expires on December 15, 2025, unless earlier terminated in accordance with the provisions of the arrangement. Mr. Van den Bosch’s arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
Guy Melamed
Chief Financial Officer and Chief Operating Officer
Adopted 10b5-1 plan Nov 24, 2024 10-K Feb 6, 2025
What the company wrote
On November 24, 2024, Guy Melamed, our Chief Financial Officer and Chief Operating Officer, entered into a Rule 10b5–1 trading arrangement. Mr. Melamed's arrangement includes the potential sale of up to 151,534 shares of our common stock, and expires on September 2, 2025, unless earlier terminated in accordance with the provisions of the arrangement. Mr. Melamed’s arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
James O’Boyle
Vice Chairman – Sales
Adopted 10b5-1 plan Nov 24, 2024 10-K Feb 6, 2025
What the company wrote
On November 24, 2024, James O’Boyle, our Vice Chairman – Sales, entered into a Rule 10b5–1 trading arrangement. Mr. O’Boyle’s arrangement includes the potential sale of up to 100,000 shares of our common stock, and expires on December 31, 2025, unless earlier terminated in accordance with the provisions of the arrangement. Mr. O’Boyle’s arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
James O’Boyle
Vice Chairman – Sales
Adopted 10b5-1 plan Mar 14, 2024 10-Q May 7, 2024
Show the other 1 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 2, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

No Form 144 notices downloaded.

From the Form 144 XML filed with the SEC. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/VRNS/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.